Literature DB >> 15464134

Recent advances in neuroproteomics and potential application to studies of drug addiction.

Kenneth Williams1, Terence Wu, Christopher Colangelo, Angus C Nairn.   

Abstract

The rapidly growing field of proteomics seeks to track changes in protein expression function that underlie the growth and differentiation of individual cell types, both during normal development and during the onset and progression of disease. Recent years have seen great strides in mRNA expression analysis, and the development of new technologies for protein profiling. However, current methods are limited to analysis of the relative expression level of only a few hundred to perhaps 2000 proteins, well below the ability of DNA microarrays to potentially interrogate the mRNA expression of more than 25,000 genes. Proteomics faces a special challenge in studies of the nervous system, where cellular and sub-cellular architecture is among the most complex in the body. This article presents an overview of current proteomic profiling technologies, reviews the recent use of some of these approaches in studies of the nervous system, and discusses the potential application of neuroproteomics to studies of drug addiction.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15464134     DOI: 10.1016/j.neuropharm.2004.07.009

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  8 in total

Review 1.  Recent advances in neuroproteomics.

Authors:  Erika C Andrade; Dilja D Krueger; Angus C Nairn
Journal:  Curr Opin Mol Ther       Date:  2007-06

Review 2.  Post-genomics nanotechnology is gaining momentum: nanoproteomics and applications in life sciences.

Authors:  Firas H Kobeissy; Basri Gulbakan; Ali Alawieh; Pierre Karam; Zhiqun Zhang; Joy D Guingab-Cagmat; Stefania Mondello; Weihong Tan; John Anagli; Kevin Wang
Journal:  OMICS       Date:  2014-01-10

3.  Persistent proteomic alterations in the medial prefrontal cortex with abstinence from cocaine self-administration.

Authors:  Melinda E Lull; Mandi S Erwin; Drake Morgan; David C S Roberts; Kent E Vrana; Willard M Freeman
Journal:  Proteomics Clin Appl       Date:  2009-03-17       Impact factor: 3.494

Review 4.  The use of neuroproteomics in drug abuse research.

Authors:  Melinda E Lull; Willard M Freeman; Heather D VanGuilder; Kent E Vrana
Journal:  Drug Alcohol Depend       Date:  2009-11-17       Impact factor: 4.492

5.  Effect of long-term exposure of SH-SY5Y cells to morphine: a whole cell proteomic analysis.

Authors:  Jérémie Neasta; Sandrine Uttenweiler-Joseph; Karima Chaoui; Bernard Monsarrat; Jean-Claude Meunier; Lionel Moulédous
Journal:  Proteome Sci       Date:  2006-12-21       Impact factor: 2.480

Review 6.  "Gestaltomics": Systems Biology Schemes for the Study of Neuropsychiatric Diseases.

Authors:  Nora A Gutierrez Najera; Osbaldo Resendis-Antonio; Humberto Nicolini
Journal:  Front Physiol       Date:  2017-05-09       Impact factor: 4.566

7.  Genes and (common) pathways underlying drug addiction.

Authors:  Chuan-Yun Li; Xizeng Mao; Liping Wei
Journal:  PLoS Comput Biol       Date:  2007-11-20       Impact factor: 4.475

8.  Exploring the nicotinic acetylcholine receptor-associated proteome with iTRAQ and transgenic mice.

Authors:  Tristan D McClure-Begley; Kathy L Stone; Michael J Marks; Sharon R Grady; Christopher M Colangelo; Jon M Lindstrom; Marina R Picciotto
Journal:  Genomics Proteomics Bioinformatics       Date:  2013-07-25       Impact factor: 7.691

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.